Politician trade (House)

Supernus Pharmaceuticals, Inc. (SUPN): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Supernus Pharmaceuticals, Inc. in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount: 14 days
Disclosure lag

Traded: Mar 24, 2025
Disclosed: Apr 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jan 27, 2025InsiderOfficer sold ~$102K of SUPN shares in the open market
Jan 28, 2025InsiderOfficer sold ~$28K of SUPN shares in the open market
Feb 4, 2025InsiderOfficer sold ~$376K of SUPN shares in the open market
Feb 21, 2025InsiderOfficer sold ~$36K of SUPN shares in the open market
Mar 24, 2025 · this disclosureCongressDisclosed purchase of SUPN — reported range $1,001 - $15,000

View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Supernus Pharmaceuticals, Inc.

OQRO holds no insider, Congress, fund or contract record for Supernus Pharmaceuticals, Inc. dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SUPN page.

Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)

The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.

How this filing works

The STOCK Act

Explore the data

Other disclosures at Supernus Pharmaceuticals, Inc.

Everything OQRO holds on this company is on its SUPN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data